Director Health System Transformation & Strategy Realization

Director Health System Transformation & Strategy Realization

Innovative Medicines Canada (IMC) offers an exciting opportunity that combines strategic planning with health system transformation. If you’re ready to translate bold vision into lasting impact, this is your chance.

This isn’t just a job—it’s a chance to make a real impact on the lives of Canadians. As the voice of Canada’s innovative pharmaceutical industry, IMC is shaping the future of healthcare—advocating for better access to life‑saving treatments and advancing innovation in the life sciences sector.

CA$/yr – CA$/yr

Direct message the job poster from Innovative Medicines Canada

Feel free to email resumes to

Position Location:
Ottawa or Toronto

Compensation: $122,000 – $167,500

The Director ensures IMC’s strategy is translated into measurable outcomes that provide real benefit to members, patients, and health systems. This hybrid role integrates:

• Health system transformation (50%): Designing and advancing policy frameworks with health system partners to integrate pharmaceutical innovation into sustainable care models and patient support approaches.
• Strategy realization (50%): Overseeing the development, engagement, approval, execution, operations, and evaluation of IMC’s strategic plan.

The Director reports to the Vice President of Strategy, System Transformation, and Research. The role works closely with the Executive Director of Strategy and Research, supports the Leadership Team, and supports governance, conference, and member engagement sessions.

• Scan and interpret trends in health system transformation across Canada and internationally.
• Align system partners through convening and consensus-building, leveraging IMC’s operational and policy platforms to bring together member companies, clinicians, patient organisations, and government agencies around shared transformation goals.
• Support the design and advance actionable frameworks that integrate pharmaceutical and biotechnological innovations into sustainable models of care.
• Foster collaborative transformation pathways with provinces, health system managers, and provider networks to demonstrate new models of integrated access, such as outcomes‑based agreements, risk‑sharing arrangements, and multidisciplinary patient‑support approaches.
• Co‑develop and test demonstration projects or pilots that show measurable system benefit, such as reduced wait times, better care coordination, or improved adherence outcomes tied to innovative medicines.
• Track and report transformation outcomes, producing clear metrics and case studies that demonstrate IMC’s leadership in shaping sustainable, innovation‑friendly health systems.

• Lead the execution of IMC’s strategy, ensuring the organization’s strategic plan is fully ope rationalised, measurable, and responsive to member priorities and system dynamics.
• Assist to establish and manage robust performance systems, including dashboards, scorecards, and milestone tracking, to ensure accountability and transparency in delivering strategic commitments.
• Embed strategic coherence into decision‑making, ensuring that emerging initiatives, partnerships, and communications consistently reinforce IMC’s long‑term direction and values.
• Support an outcomes‑based culture, linking each strategic initiative to explicit benefit‑realisation metrics, performance indicators, and system‑level impact.
• Support evidence‑informed governance, providing the Leadership Team, Executive Committee, and Board with timely data and insight to guide resource allocation and risk management.
• Ensure alignment with external stakeholders, coordinating IMC’s strategic cycles with member companies, policy agencies, and system partners to maintain relevance and momentum.
• Continuously refine IMC’s strategy‑realisation discipline, embedding lessons from past cycles and external partnerships to enhance coherence, agility, and credibility.
• Act as the guardian of strategic coherence, promoting disciplined execution, consistency of messaging, and a “One‑IMC” approach across all activities, engagements, and deliverables.